Schwartz, Sherwyn

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

Zinman, B., Gerich, J., Buse, J. B., Lewin, A., Schwartz, S., Raskin, P., Hale, P. M., Zdravkovic, M., Blonde, L., & the LEAD-4 Study Investigators (2009) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 848

Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes

Rosenstock, J., Klaff, L. J., Schwartz, S., Northrup, J., Holcombe, J. H., Wilhelm, K., & Trautmann, M. (2010) · Diabetes Care

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 229

Glycemic Characteristics in Continuously Monitored Patients With Type 1 and Type 2 Diabetes

Bode, B. W., Schwartz, S., Stubbs, H. A., & Block, J. E. (2005) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 137

Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral Drugs

Schwartz, S., Sievers, R., Strange, P., Lyness, W. H., Hollander, P., & For The INS-2061 Study Team (2003) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 117

Only Multiple Autoantibodies to Islet Cells (ICA), Insulin, GAD65, IA-2 and IA-2β Predict Immune-Mediated (Type 1) Diabetes in Relatives

Maclaren, N., Lan, M., Coutant, R., Schatz, D., Silverstein, J., Muir, A., Clare-Salzer, M., She, J.-X., Malone, J., Crockett, S., et al. (1999) · Journal of Autoimmunity

Diabetes and associated disordersDiabetes Management and Research

Cited by 117